Gyeonggi-do, South Korea

Wonduck Kim

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignee: Genome and Company. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wonduck Kim. Retrieved from https://idiyas.com/inventor/wonduck-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Wonduck Kim

Introduction

Wonduck Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on developing strains that can prevent or treat various types of cancers.

Latest Patents

Wonduck Kim holds a patent for strains that have effects in preventing or treating cancers. The patent describes a novel MG731 strain, which has demonstrated the ability to inhibit the proliferation of cancer cells, decrease their mobility, and enhance the anticancer immune response. Additionally, the MG731 strain reduces the expression of inflammatory factors, making it effective in preventing or treating cancers and inflammatory diseases. Furthermore, when combined with anticancer chemotherapeutic or immunotherapeutic agents, the MG731 strain exhibits improved anticancer effects. Another strain, GEN3033, is also highlighted in his patent. This strain directly inhibits cancer cell proliferation and enhances immunity, showcasing its potential in cancer prevention and treatment. The GEN3033 strain secretes metabolites with anticancer properties while established in the gut, further enhancing its effectiveness when used alongside other treatments.

Career Highlights

Wonduck Kim is associated with Genome and Company, where he continues to advance his research in cancer treatment. His innovative approaches and dedication to improving health outcomes have positioned him as a key figure in the field of biotechnology.

Collaborations

He collaborates with notable colleagues, including Hansoo Park and Shinyoung Park, who contribute to his research efforts and innovations in cancer treatment.

Conclusion

Wonduck Kim's work in developing novel strains for cancer treatment represents a significant advancement in medical science. His patented inventions have the potential to improve therapeutic outcomes for cancer patients, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…